4.2 Review

Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection

Pandora L. Wander et al.

Summary: This study found that SARS-CoV-2 infection is associated with a higher risk of incident diabetes in men, but not in women, even after accounting for hospital surveillance.

DIABETES CARE (2022)

Letter Endocrinology & Metabolism

Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study

Morgan Birabaharan et al.

DIABETES OBESITY & METABOLISM (2022)

Review Endocrinology & Metabolism

Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence

Rimesh Pal et al.

Summary: COVID-19 affects multiple endocrine organ systems during the disease course. Limited follow-up data suggest that most of the biochemical endocrine dysfunctions observed during acute phase of COVID-19 tend to improve after recovery. New-onset diabetes mellitus has been described post-acute COVID-19, while thyroid/adrenal functions usually normalize on follow-up. Pituitary apoplexy and male hypogonadism have rarely been documented in COVID-19. Routine estimation of serum calcium post-COVID-19 is not warranted.

ENDOCRINE PRACTICE (2022)

Article Cell Biology

Limited extent and consequences of pancreatic SARS-CoV-2 infection

Verena van der Heide et al.

Summary: In this study, comprehensive single-cell analysis of SARS-CoV-2-infected human pancreatic islets revealed that the infection is strictly dependent on the ACE2 receptor and targets various pancreatic cell types. However, the infection is limited and non-cytopathic, causing only mild cellular perturbations and inflammatory responses. Similar outcomes were observed with endemic coronaviruses. Further evaluation is needed to determine if COVID-19-induced damage to the pancreas and immunological changes increase the risk of diabetes.

CELL REPORTS (2022)

Article Public, Environmental & Occupational Health

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged

Catherine E. Barrett et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Article Pediatrics

New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic

Heli Salmi et al.

Summary: A Finnish retrospective cohort study found that more children with T1D had severe DKA at diagnosis during the pandemic due to delays in presentation and diagnosis, rather than a consequence of SARS-CoV-2 infection.

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Article Endocrinology & Metabolism

Incidence of newly diagnosed diabetes after Covid-19

Wolfgang Rathmann et al.

Summary: This study investigated the incidence of diabetes after infection with Covid-19. The results showed that individuals with Covid-19 had an increased incidence of type 2 diabetes compared to those with acute upper respiratory tract infections (AURI). These findings support the active monitoring of glucose dysregulation after recovery from mild Covid-19.

DIABETOLOGIA (2022)

Article Endocrinology & Metabolism

Risks and burdens of incident diabetes in long COVID: a cohort study

Yan Xie et al.

Summary: This study found an increased risk and burden of incident diabetes and antihyperglycaemic use in people with COVID-19 in the post-acute phase compared to a contemporary control group. The risks and burdens of post-acute outcomes were related to the severity of the acute phase of COVID-19.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection

Pandora L. Wander et al.

Summary: This study found that SARS-CoV-2 infection is associated with a higher risk of incident diabetes in men but not in women, even after accounting for hospital surveillance.

DIABETES CARE (2022)

Letter Endocrinology & Metabolism

Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis

Thirunavukkarasu Sathish et al.

DIABETES OBESITY & METABOLISM (2021)

Article Endocrinology & Metabolism

COVID-19, Hyperglycemia, and New-Onset Diabetes

Kamlesh Khunti et al.

Summary: New-onset diabetes is common among COVID-19 patients and may impact disease severity and outcomes. The underlying mechanisms are complex and require further research. Hospitals should prioritize identification and management of acute hyperglycemia.

DIABETES CARE (2021)

Article Multidisciplinary Sciences

High-dimensional characterization of post-acute sequelae of COVID-19

Ziyad Al-Aly et al.

Summary: This study comprehensively describes the post-acute sequelae of COVID-19 using national healthcare databases, finding increased risk of death and use of health resources beyond the first 30 days of illness, as well as incident sequelae in various organ systems, increased use of therapeutic agents, and evidence of laboratory abnormalities. The findings show a risk gradient according to the severity of acute COVID-19 infection and highlight the burden of health loss experienced by patients who survive the acute phase.

NATURE (2021)

Article Medicine, General & Internal

Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study

Daniel Ayoubkhani et al.

Summary: Patients discharged from the hospital after COVID-19 were found to have increased rates of multiorgan dysfunction, with higher risk not only limited to the elderly but also varying across ethnic groups.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Medicine, General & Internal

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study

Sarah E. Daugherty et al.

Summary: The study evaluated the excess risk and relative hazards for developing incident clinical sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. The results show that individuals infected with SARS-CoV-2 may have a higher risk of developing new clinical sequelae after the acute phase compared to the control groups, with some sequelae more commonly seen in other viral illnesses.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Endocrinology & Metabolism

Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium

Anissa Messaaoui et al.

Summary: The study found that 20% of children developing type 1 diabetes in Belgium during the pandemic tested positive for anti-SARS-CoV-2 antibodies. Children without anti-SARS-CoV-2 antibodies had significantly higher frequencies of insulinoma-associated protein 2 antibodies positivity.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection

Laura Montefusco et al.

Summary: Patients with COVID-19 may experience hyperglycaemia, insulin resistance, and abnormal glucose metabolism, with these glycaemic abnormalities potentially persisting for at least 2 months after recovery. Further research into metabolic abnormalities in the context of long COVID is warranted.

NATURE METABOLISM (2021)

Editorial Material Endocrinology & Metabolism

COVID-19 and the endocrine system: exploring the unexplored

R. Pal et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)

Article Endocrinology & Metabolism

Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study

Paz L. D. Ruiz et al.

DIABETOLOGIA (2018)

Article Medicine, General & Internal

Influenza

Florian Krammer et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Review Mathematical & Computational Biology

Assessing the quality of studies in meta-analyses: Advantages and limitations of the Newcastle Ottawa Scale

Claudio Luchini et al.

WORLD JOURNAL OF META-ANALYSIS (2017)

Editorial Material Public, Environmental & Occupational Health

The Hazards of Hazard Ratios

Miguel A. Hernan

EPIDEMIOLOGY (2010)